Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, and Saudi Arabia. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. In addition, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its name to Klea Holding SA in June 2024. Klea Holding SA was founded in 2007 and is headquartered in Paris, France.…
Graphique des rendements saisonniers Klea Holding SA (ALKLH.PA)
Klea Holding (EPA: ALKLH) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 112 employees.
The shares were at 0.1622 EUR on 20 November 2026, down 33.8% over 52 weeks. Its 52-week range is 0.1040 EUR to 0.2560 EUR: the price is 36.6% below the high and 56.0% above the low.
Its market capitalisation is 49.74M EUR.
Klea Holding reports return on equity of 8.3%, an operating margin of 14.1% and revenue down 24.7% year over year.
Its debt exceeds its cash by 1.69M EUR, a debt-to-equity ratio of 0.19. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health.
No upcoming events tracked.